OncoSec Medical Inc (ONCSQ)

[hschlauch]

It might very well be, but I think there is probably a little more to the rationale. I do get the sense that the company and collaborators are genuinely excited to share more information with investors AND THE SCIENTIFIC COMMUNITY. They are stacking up conference appearances, not just to present, but also I think, to gauge how significant their data are relative to current breakthroughs. They seem to be keenly aware of all combination trials.

I think dilution is always a strong possibility for companies at this stage of development, but at what price would the offering(s) be in the case of ONCS?